-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Cancer Research UK, a commercial leader in cancer research technology, has reached an agreement with Chengdu Pilot Drug Development Co., Ltd. to develop a new drug to fight lung cancer.
at the University of Manchester's charity Drug Research and Development Group will use a leading technology platform developed by pilot companies to target lung cancer treatment, which screens out HUNDREDS of small drug-like molecules that are synthesized from a variety of chemicals.
both sides noted that this was the first licence to be obtained through an ongoing partnership between CRT, Cancer Research UK's Manchester Institute Drug Discovery Group and HitGen, and that As the project progresses, Pilot Drug Development Ltd. will provide landmark funding for research and development.
As part of Cancer Research UK's Lung Cancer Centre, we will decide to develop new drugs to enable patients to be treated more quickly," he said. This promising drug offers potential to help patients pull back from ghost doors," said Dr Donald Ogilvie, head of the Cancer Institute in Manchester, UK.
further special effects have not been revealed this time. (China Pharmaceutical 123 Network)